AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2021 Issue 4; Section X-New Technology

Introduction of New Therapeutic Substances

Effective October 1, 2021, eight new substance values were added to code Table XW0, Anatomical Regions, Introduction, for the eight substances listed below. Please note that all of the substances below have a qualifier of 7, New Technology Group 7.   Device/Substance/Technology 2 Bromelain-enriched Proteolytic Enzyme 5 Narsoplimab Monoclonal Antibody 6 Terlipressin 7 Trilaciclib 8 Lurbinectedin 9 Satralizumab-mwge B Amivantamab Monoclonal Antibody L Lifileucel Immunotherapy Bromelain-enriched Proteolytic Enzyme NexoBrid™ is a mixture of proteolytic enzymes (enriched in bromelain) used for eschar removal in adults with deep partial thickness and/or full thickness thermal burns. The proteolytic enzymes can be applied...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.